Dylan Beynon, CEO of Mindbloom, talks about why he started this company, the impact of Ketamine and MDMA therapy in our society, and how this industry is just going to grow bigger in the future.
TIME-STAMPED SHOW NOTES:
[00:00] – Know more about Dylan Beynon and his company, Mindbloom
[02:30] – Why did Dylan Beynon start Mindbloom
[06:22] – Dylan Beynon talks more about MDMA therapy
[13:30] – Pricing and treatment programs that Mindbloom offer
[15:30] – Dylan Beynon’s personal opinion on MDMA and Ketamine therapy
[22:12] – The largest peer review clinical study for psychedelic and ketamine therapy
[25:20] – The best mental health tool for Dylan Beynon
[27:53] – Dylan Beynon talks about Vipassana Meditation
[36:00] – Where to find Dylan Beynon and learn more about Mindbloom
Go to https://www.marketingschool.io to learn more!
Don’t forget to help us grow by subscribing and liking on YouTube!
Leave Some Feedback:
What should we talk about next? Please let us know in the comments below
Did you enjoy this episode? If so, please leave a short review.
Connect with Us:
Single Grain << Eric’s ad agency
NP Digital << Neil’s ad agency
X @neilpatel
X @ericosiu
Discover Latest Episodes
Neil and Eric break down why high agency is becoming more valuable than raw intelligence in the age of AI. They discuss Andre Karpathy’s views, Klarna’s AI experiment, why speed and execution now ...
In this episode, hosts Neil and Eric break down how operator creators should price influencer deals, why most founders undercharge, and when sponsorships hurt long term business growth. They share rea...
In this episode, Neil and Eric break down why running a company feels like a sandwich every day, from CEO pressure and people problems to impostor syndrome and nonstop decision making. They compare fo...